A. Darragh

2.7k total citations
71 papers, 1.1k citations indexed

About

A. Darragh is a scholar working on Pharmacology, Analytical Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Darragh has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 18 papers in Analytical Chemistry and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Darragh's work include Analytical Methods in Pharmaceuticals (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Pharmacology and Obesity Treatment (7 papers). A. Darragh is often cited by papers focused on Analytical Methods in Pharmaceuticals (18 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Pharmacology and Obesity Treatment (7 papers). A. Darragh collaborates with scholars based in Ireland, United States and Switzerland. A. Darragh's co-authors include R. Lambe, L. F. Chasseaud, I. Brick, Ciaran A. O’Boyle, Marie Kenny, T. Taylor, Andrew Abdulahad, Patrick Salmon, Andrew Galazka and M. Moriarty and has published in prestigious journals such as The Lancet, Journal of Chromatography A and Psychopharmacology.

In The Last Decade

A. Darragh

68 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Darragh Ireland 19 199 182 143 140 127 71 1.1k
Bengt Dahlström Sweden 23 192 1.0× 229 1.3× 87 0.6× 89 0.6× 179 1.4× 41 1.9k
Eppo van der Kleijn Netherlands 24 274 1.4× 258 1.4× 383 2.7× 169 1.2× 234 1.8× 66 1.5k
Samson Symchowicz United States 22 204 1.0× 268 1.5× 49 0.3× 96 0.7× 124 1.0× 58 1.2k
R Arendt Germany 21 124 0.6× 256 1.4× 150 1.0× 48 0.3× 380 3.0× 59 1.5k
Scott R. Hamann United States 16 125 0.6× 207 1.1× 95 0.7× 89 0.6× 140 1.1× 37 929
Edward J. Randinitis United States 18 194 1.0× 231 1.3× 246 1.7× 75 0.5× 97 0.8× 43 1.3k
D. Platt Germany 18 81 0.4× 228 1.3× 81 0.6× 36 0.3× 103 0.8× 91 1.2k
G. E. Mawer United Kingdom 22 206 1.0× 223 1.2× 617 4.3× 52 0.4× 166 1.3× 50 1.9k
W Theobald Switzerland 16 255 1.3× 171 0.9× 96 0.7× 114 0.8× 172 1.4× 47 872
C Crevoisier Switzerland 17 133 0.7× 65 0.4× 148 1.0× 49 0.3× 84 0.7× 40 888

Countries citing papers authored by A. Darragh

Since Specialization
Citations

This map shows the geographic impact of A. Darragh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Darragh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Darragh more than expected).

Fields of papers citing papers by A. Darragh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Darragh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Darragh. The network helps show where A. Darragh may publish in the future.

Co-authorship network of co-authors of A. Darragh

This figure shows the co-authorship network connecting the top 25 collaborators of A. Darragh. A scholar is included among the top collaborators of A. Darragh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Darragh. A. Darragh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bateman, Lucinda, et al.. (2012). MYALGIC ENCEPHALOMYELITIS - Adult & Paediatric: International Consensus Primer for Medical Practitioners. 22 indexed citations
3.
Salmon, Patrick, et al.. (1996). Pharmacokinetics and Pharmacodynamics of Recombinant Human Interferon-β in Healthy Male Volunteers. Journal of Interferon & Cytokine Research. 16(10). 759–764. 145 indexed citations
4.
Taylor, T., et al.. (1991). Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states. European Journal of Clinical Pharmacology. 40(1). 101–106. 5 indexed citations
5.
Roth, W., et al.. (1990). Pharmacokinetics of Falipamil after Intravenous Administration to Humans. Journal of Pharmaceutical Sciences. 79(5). 415–419. 2 indexed citations
6.
Guinot, Pierre‐Grégoire, et al.. (1989). Tanakan Inhibits Platelet-Activating-Factor-Induced Platelet Aggregation in Healthy Male Volunteers. Pathophysiology of Haemostasis and Thrombosis. 19(4). 219–223. 32 indexed citations
7.
Saletu, B., A. Darragh, Paul M. Salmon, & Robert F. Coen. (1989). EEG brain mapping in evaluating the time‐course of the central action of DUP 996‐a new acetylcholine releasing drug.. British Journal of Clinical Pharmacology. 28(1). 1–16. 32 indexed citations
8.
Wood, Stuart, B. A. John, L. F. Chasseaud, et al.. (1987). Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog. Xenobiotica. 17(7). 881–896. 5 indexed citations
9.
Hayden, Frederick G., et al.. (1987). Tolerance and nasal histopathologic effects of long-term, low-dose intranasal recombinant interferon alpha-2A (Roferon-A). Antiviral Research. 8(3). 139–149. 8 indexed citations
10.
Madden, Erin, et al.. (1987). Aggregation Responses to Platelet-Activating Factor in Normal Subjects. Pathophysiology of Haemostasis and Thrombosis. 17(3). 171–172. 1 indexed citations
11.
Brodie, R.R., L. F. Chasseaud, A. Darragh, et al.. (1986). Pharmacokinetics and bioavailability of the anti‐emetic agent bromopride. Biopharmaceutics & Drug Disposition. 7(3). 215–222. 7 indexed citations
12.
Darragh, A., et al.. (1985). Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults. European Journal of Clinical Pharmacology. 28(3). 305–309. 25 indexed citations
13.
Lambe, R., et al.. (1983). The effect of PK 5078, a new serotonin uptake inhibitor, on serotonin levels and uptake in human platelets, following administration to healthy volunteers. European Journal of Clinical Pharmacology. 25(1). 23–28. 6 indexed citations
14.
O’Boyle, Ciaran A., et al.. (1983). RO 15–1788 ANTAGONIZES THE EFFECTS OF DIAZEPAM IN MAN WITHOUT AFFECTING ITS BIOAVAILABILITY. British Journal of Anaesthesia. 55(4). 349–356. 78 indexed citations
15.
Wood, Stuart, B. A. John, L. F. Chasseaud, et al.. (1983). The metabolism of the anti-inflammatory drug eterylate in rat, dog and man. Xenobiotica. 13(12). 731–742. 1 indexed citations
16.
Brodie, R.R., et al.. (1982). Bioavailability of bemetizide and triamterene from a combination formulation. Biopharmaceutics & Drug Disposition. 3(4). 361–370. 7 indexed citations
17.
Darragh, A., et al.. (1982). RO 15‐1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.. British Journal of Clinical Pharmacology. 14(5). 677–682. 79 indexed citations
18.
Darragh, A., et al.. (1981). Effects of Ro 11-2465, a new psychotropic agent on the uptake of serotonin by human platelets--in vitro determination of the IC50.. PubMed. 249(1). 147–52. 7 indexed citations
19.
Biggs, Simon, et al.. (1980). The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans. Xenobiotica. 10(12). 873–888. 3 indexed citations
20.
Darragh, A., et al.. (1964). Toxaemia of Pregnancy. BMJ. 2(5411). 762.2–762. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bengt Dahlström Breakdown of academic impact, for papers by Eppo van der Kleijn Breakdown of academic impact, for papers by Samson Symchowicz Breakdown of academic impact, for papers by R Arendt Breakdown of academic impact, for papers by Scott R. Hamann Breakdown of academic impact, for papers by Edward J. Randinitis Breakdown of academic impact, for papers by D. Platt Breakdown of academic impact, for papers by G. E. Mawer Breakdown of academic impact, for papers by W Theobald Breakdown of academic impact, for papers by C Crevoisier
Rankless by CCL
2026